| 1.56 -0.06 (-3.7%) | 09-01 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.17  |
1-year : | 2.41 |
| Resists | First : | 1.85 |
Second : | 2.06 |
| Pivot price | 1.7 |
|||
| Supports | First : | 1.51 |
Second : | 1.26 |
| MAs | MA(5) : | 1.63 |
MA(20) : | 1.74 |
| MA(100) : | 1.57  |
MA(250) : | 1.78 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 15.1 |
D(3) : | 20.5 |
| RSI | RSI(14): 35.7 |
|||
| 52-week | High : | 4.19 | Low : | 1.09 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ CBUS ] has closed above bottom band by 9.6%. Bollinger Bands are 33% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.62 - 1.63 | 1.63 - 1.64 |
| Low: | 1.49 - 1.51 | 1.51 - 1.52 |
| Close: | 1.54 - 1.56 | 1.56 - 1.58 |
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Sun, 23 Aug 2026
CBUS | Cibus, Inc. Class A Financials - Revenue Breakdown - Quiver Quantitative
Tue, 18 Aug 2026
HC Wainwright Estimates Cibus' Q3 Earnings (NASDAQ:CBUS) - MarketBeat
Thu, 13 Aug 2026
Cibus: Q2 Earnings Snapshot - KVUE
Thu, 13 Aug 2026
Cibus (CBUS) narrows Q2 2026 loss as cash burn falls and regulatory tailwinds build - Stock Titan
Wed, 12 Aug 2026
Earnings To Watch: Cibus Inc (CBUS) Q2 2026 -- GF Value Sees 14% Downside - Yahoo Finance
Mon, 10 Aug 2026
Cibus Inc. (CBUS) Jumps 6.6% to $1.93, Holding Above Key Support - Bullish Pattern Stocks - vinanet.vn
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 76 (M) |
| Held by Insiders | 5.724e+007 (%) |
| Held by Institutions | 26.1 (%) |
| Shares Short | 4,630 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -4.887e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 300.2 % |
| Return on Equity (ttm) | -10.3 % |
| Qtrly Rev. Growth | 4.35e+006 % |
| Gross Profit (p.s.) | 4.01 |
| Sales Per Share | -137.76 |
| EBITDA (p.s.) | 2.68519e+006 |
| Qtrly Earnings Growth | -1.6 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -46 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.02 |
| Price to Cash Flow | 13.3 |
| Dividend | 0 |
| Forward Dividend | 3.62e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|